A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
Titel:
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
Auteur:
Ciuleanu, T. Tsai, C.-M. Tsao, C.-J. Milanowski, J. Amoroso, D. Heo, D.S. Groen, H.J.M. Szczesna, A. Chung, C.-Y. Chao, T.-Y. Middleton, G. Zeaiter, A. Klingelschmitt, G. Klughammer, B. Thatcher, N.